Profound Medical Corp Upsizes Private Placement to $6.45M to Fund Sales, R&D Expansion

MT Newswires Live2025-12-26

Profound Medical Corp (PROF) on Wednesday said it had increased the size of its previously announced private placement to raise $6.45 million.

The medical technology firm plans to issue up to 921,428 common shares at a price of $7 per share. The offering was first announced on Dec. 19. Closing is expected on or before Dec. 30. The increase was made to accommodate participation from a long-term existing investor, the company said.

Shares issued under the offering will be subject to a hold period of four months plus one day.

Profound intends to use the net proceeds to expand sales and marketing operations. Funds will also support working capital needs, research and development, strategic transactions and general corporate purposes.

The company said no securities will be sold to U.S. purchasers.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment